Scientists Outline Steps For Safely Receiving COVID-19 Vaccine

0
Following accounts of potential allergies to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, scientists have outlined steps on safely receiving the second dose of the therapeutic in individuals who develop a reaction to their first dose. The research, published in the Journal of Allergy and Clinical Immunology: In Practice, summarised what is currently known about allergic reactions to vaccines...

“Plan To Cover 25 Crore By Next July”: Health Minister On Covid Vaccine

0
The government plans to provide Covid vaccines to around 25 crore (250 million) people - of the country's 130 crore (1.3 billion) - by July 2021, Union Health Minister Dr Harsh Vardhan said Sunday afternoon. Dr Vardhan said the government would receive between 400 and 500 million vaccine doses for this purpose and that it would ensure "equitable access". The...

Cadila Healthcare stock erases opening gains, Zydus gets USFDA nod for oral iron chelator

0
Cadila Healthcare share price erased opening gains after rising more than a percent due to tentative approval from the US health regulator for the oral iron chelator. The company in its filing said its group company Zydus has received tentative approval from the US Food and Drug Administration for Deferasirox. Cadila Healthcare stock erases opening gains, Zydus gets...

Covid Vaccine 90% Effective In Phase 3 Trial, Says Pfizer

0
A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies announced Monday. The statement was released as coronavirus cases are soaring across the world, and European stock markets and oil prices jumped on the news. According to preliminary findings, protection in patients was achieved seven days after the...

No Deaths Directly Linked To COVID-19 Vaccine Shots In Europe, Say Experts

0
Despite dozens of deaths of people shortly after they were vaccinated against coronavirus, scientists say the evidence available so far does not incriminate the new anti-Covid vaccines. Health agencies stress however that the vast majority of post-vaccination fatalities were elderly, already vulnerable and often sick. Here's a review of the situation: Elderly, vulnerable Norway sparked alarm last week when it reported the deaths...

Sun Pharma, Dilip Shanghvi and other officials settle case of alleged market norms violation with Sebi

0
Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday, settled with regulator Sebi a case pertaining to an alleged violation of listing obligation and disclosure requirements norms. According to separate settlement orders, Sun Pharmaceutical paid over Rs 56.11 lakh towards settlement charges and Shanghvi paid Rs 62.35 lakh. Besides, the firm's whole-time directors...

A Meagre 2% of Medicines Undergo Quality Control Checks: Says Former IMA President

0
Press Release - A Meagre 2% of Medicines Undergo Quality Control Checks: Says Former IMA President
Illuminating a compelling need for rigorous regulation New Delhi, August 30, 2023: In a riveting discourse that left the healthcare sector captivated, a profound webinar titled 'Demystifying the NMC Guidelines Conundrum' unfolded against the backdrop of the recent postponement of the National Medical Commission (NMC) guidelines. In this intellectual rendezvous, luminaries in their respective fields convened to deliberate the path towards...

AstraZeneca’s Covid-19 Vaccine Set To Become First One Approved In India: Report

0
India's drug regulator, Drugs Controller General of India, is set to approve on Friday a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, three sources with knowledge of the matter said. The decision would pave the way for the vaccine's rollout in the world's second-most populous country which, after the United States, has the highest number of...

Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill

0
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the  Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement. The pause means the online...

In a First For Southeast Asia, Malaysia Signs Deal With Pfizer for Vaccine

0
Malaysia has agreed to buy 12.8 million doses of Pfizer's COVID-19 vaccine, becoming the first country in Southeast Asia to announce a deal with the US drugmaker after some expressed reservations over the need for ultra-cold storage. While final trial data showed that Pfizer's vaccine is 95 per cent effective, many Asian countries are not betting on it partly due...